News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Work in funding medicines for rare disorders progressing

PHARMAC work in funding medicines for rare disorders progressing

PHARMAC is progressing work aimed at improving funded access to medicines for rare disorders.

Chief Executive Sarah Fitt says the latest step is the appointment of a clinical subcommittee with expertise in evaluating medicines for rare disorders. The subcommittee, which includes leading New Zealand and Australian experts in managing patients with rare disorders, will provide advice to PHARMAC’s main clinical committee, PTAC.

Earlier in the month, PHARMAC published updated policy settings for assessing medicines for rare disorders, and opened a commercial process seeking funding applications from pharmaceutical suppliers, specifically for medicines for rare disorders.

“We’re pleased to have made this progress following on from the commitments we made at the end of last year,” says Sarah Fitt. “The subcommittee will provide expert clinical advice on applications we receive from the commercial process we are currently running. This involves actively seeking funding proposals for medicines for rare disorders.”

“The updated policy settings help define which medicines we will consider in this process, and provide certainty to stakeholders of the sort of medicines we are looking for.

“Ultimately, we hope this work will improve access to funded medicines for people with rare disorders.”

PHARMAC has also made a decision to change, and widen access to, the funded enzyme replacement therapy for the rare disorder Gaucher disease. Taliglucerase will be phased in from 1 August 2018 to replace the currently funded treatment, imiglucerase.

PHARMAC had earlier run a dedicated contestable process specifically for medicines for rare disorders, which resulted in decisions to list 10 medicines on the Pharmaceutical Schedule.

ENDS


© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Oscar Buzz: Waititi's Jojo Rabbit Wins People's Choice Award At Toronto

Taika Waititi's new film Jojo Rabbit has nabbed the coveted Grolsch People's Choice Award at the close of Toronto International Film Festival. More>>

ALSO:

Broken Estate: An Expat Expert Surveys Our Media

Melanie Bunce cut her teeth in journalism at the Otago Daily Times. Now she teaches and researches it at one of the UK’s most prestigious journalism schools and tracks the trends that shape the uncertain future of news... More>>

Controversial Reforms: Te Papa Chief Executive To Step Down

Te Papa’s Chief Executive Geraint Martin announced today he will step down from the role at the end of the year. Mr Martin said he had achieved what he set out to do at the museum, and Te Papa was in a strong position for the future. More>>

ALSO:

A City Possessed: New Edition Of Book Coincides With Ellis Case Appeal

Originally published in 2001, A City Possessed is the harrowing account of one of New Zealand’s most high-profile criminal cases – a story of child sexual abuse allegations, gender politics and the law. More>>

ALSO:

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland